Inflammatory bowel disease

Original
Year 2025 / Volume 117 / Number 4
205-212
DOI: 10.17235/reed.2024.10521/2024
Carles Iniesta-Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo, Isabel Nicolás-de Prado, Rosa Gómez-Espín, Elena Urbieta-Sanz,
Background: understanding the relationship between ustekinumab (UST) exposure and clinical outcomes in inflammatory bowel disease (IBD) induction is crucial. However, evidence remains limited, highlighting...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 4
230-231
DOI: 10.17235/reed.2024.10348/2024
Yi Lu, Hailing Liu, Xiaoying Lou, Jiachen Sun,
Patients with ulcerative colitis are at increased risk for colorectal neoplasia compared to the general population. The risk factors include family history of colorectal cancer, wide extent of colitis,...
Reader rating:
Review
Year 2025 / Volume 117 / Number 3
129-135
DOI: 10.17235/reed.2023.9444/2022
Rui Li, Lei Yang,
In recent years, more and more drugs have been used in the treatment of ulcerative colitis, but the efficacy of monotherapy is limited, especially for patients with refractory moderate to severe ulcerative...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 2
119-120
DOI: 10.17235/reed.2024.10214/2023
Rodrigo Meza, Teresa Peralta, Diego Ruedi, Alex Arenas Aravena,
We report the case of a 34-year-old female with Crohn’s disease (CD), was treated with infliximab and ileocecal resection after failure to anti-TNF. She started adalimumab for postoperative recurrence...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 2
113-114
DOI: 10.17235/reed.2024.10290/2024
Eugenia Navarro Moreno, Marta Lázaro Sáez, José Luis Vega Sáenz,
Both psoriasis and inflammatory bowel disease (IBD) are immunomediated diseases. Some of their therapeutic tools are monoclonal antibodies. Ixekizumab is an interleukin-17 (IL-17) inhibitor approved for...
Reader rating:
Editorial
Year 2024 / Volume 116 / Number 12
657-660
DOI: 10.17235/reed.2024.10764/2024
Fernando Gomollón,
Except for some surgical techniques, up to 1940 the clinical course of inflammatory bowel disease was determined by its own natural history: most medical interventions even worsened prognosis. The empyrical...
Reader rating:
Letter
Year 2024 / Volume 116 / Number 12
732-733
DOI: 10.17235/reed.2024.10140/2023
João Correia, Maria Manuela Estevinho, Pedro Mesquita, Catarina Costa, Teresa Freitas,
A 66-year-old man was admitted to the emergency department due to malaise, fatigue and anorexia for the last 2 weeks. He presented no fever, no respiratory or gastrointestinal symptoms. The patient had...
Reader rating:
Letter
Year 2024 / Volume 116 / Number 12
724-725
DOI: 10.17235/reed.2024.10865/2024
Carolina Broco Fernández, Mónica Sierra Ausín, Irene Latras Cortés, Verónica Patiño Delgadillo, Patricia Suárez Álvarez, Francisco Jorquera Plaza,
We present the case of a 64-year-old male diagnosed with corticosteroid-dependent ulcerative colitis in 1999, who underwent total proctocolectomy with a J-pouch in 2005. Three years later, he developed...
Reader rating:
Original
Year 2024 / Volume 116 / Number 11
606-612
DOI: 10.17235/reed.2024.10489/2024
José Ramón Lorente, José María Paredes, Pilar Llopis, Tomás Ripollés, Alba Voces, Ángela Algarra, Carmina Asencio, Patricia Latorre, Nadia Moreno, Antonio López-Serrano, Eduardo Moreno-Osset,
Background: anti-TNF drugs have revolutionized the treatment of Crohn’s disease (CD) and have set new therapeutic targets. A direct correlation between anti-TNF trough levels and endoscopic healing in...
Reader rating:
Letter
Year 2024 / Volume 116 / Number 11
645-646
DOI: 10.17235/reed.2024.10168/2023
Álvaro Yagüe Parada, Orencio Bosch Esteva, Daniel Calero Barón, Andrea Blanco Fernández, Víctor Manuel Castellano Megías, Sara Aurora Rodríguez Vargas,
Epstein-Barr virus-positive mucocutaneous ulcer (EBVMCU) is a new entity recently included in the classification of B-cell lymphoproliferative disorders associated with Epstein-Barr virus (EBV). It is...
Reader rating:

Page 1 of 17
1
2
3
4
5
6
7
>>
Submission and tracking of manuscripts
Instructions to authors

Submission and tracking

Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2025 y Creative Commons. The Spanish Journal of Gastroenterology